228 related articles for article (PubMed ID: 24285579)
1. Multiple-site activation of the cysteinyl leukotriene receptor 2 is required for exacerbation of ischemia/reperfusion injury.
Ni NC; Ballantyne LL; Mewburn JD; Funk CD
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):321-30. PubMed ID: 24285579
[TBL] [Abstract][Full Text] [Related]
2. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
3. The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen-induced retinopathy.
Barajas-Espinosa A; Ni NC; Yan D; Zarini S; Murphy RC; Funk CD
FASEB J; 2012 Mar; 26(3):1100-9. PubMed ID: 22131271
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury.
Jiang W; Hall SR; Moos MP; Cao RY; Ishii S; Ogunyankin KO; Melo LG; Funk CD
Am J Pathol; 2008 Mar; 172(3):592-602. PubMed ID: 18276782
[TBL] [Abstract][Full Text] [Related]
5. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure.
Hui Y; Cheng Y; Smalera I; Jian W; Goldhahn L; Fitzgerald GA; Funk CD
Circulation; 2004 Nov; 110(21):3360-6. PubMed ID: 15545522
[TBL] [Abstract][Full Text] [Related]
6. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cysteinyl leukotriene 2 receptor expression and myocardial ischemia/reperfusion injury.
Moos MP; Funk CD
Trends Cardiovasc Med; 2008 Oct; 18(7):268-73. PubMed ID: 19232956
[TBL] [Abstract][Full Text] [Related]
8. Cysteinyl leukotriene 2 receptor promotes endothelial permeability, tumor angiogenesis, and metastasis.
Duah E; Teegala LR; Kondeti V; Adapala RK; Keshamouni VG; Kanaoka Y; Austen KF; Thodeti CK; Paruchuri S
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):199-204. PubMed ID: 30559191
[TBL] [Abstract][Full Text] [Related]
9. Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.
Luo T; Chen B; Zhao Z; He N; Zeng Z; Wu B; Fukushima Y; Dai M; Huang Q; Xu D; Bin J; Kitakaze M; Liao Y
Basic Res Cardiol; 2013 May; 108(3):342. PubMed ID: 23467745
[TBL] [Abstract][Full Text] [Related]
10. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
[TBL] [Abstract][Full Text] [Related]
11. Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice.
Adamek A; Jung S; Dienesch C; Laser M; Ertl G; Bauersachs J; Frantz S
Eur J Pharmacol; 2007 Sep; 571(1):51-4. PubMed ID: 17586489
[TBL] [Abstract][Full Text] [Related]
12. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse.
Parapanov R; Lugrin J; Rosenblatt-Velin N; Feihl F; Waeber B; Milano G; Vergely C; Li N; Pacher P; Liaudet L
Clin Sci (Lond); 2015 Jul; 129(2):187-98. PubMed ID: 25757463
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport.
Moos MP; Mewburn JD; Kan FW; Ishii S; Abe M; Sakimura K; Noguchi K; Shimizu T; Funk CD
FASEB J; 2008 Dec; 22(12):4352-62. PubMed ID: 18779380
[TBL] [Abstract][Full Text] [Related]
15. Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT₂ receptor.
Capra V; Carnini C; Accomazzo MR; Di Gennaro A; Fiumicelli M; Borroni E; Brivio I; Buccellati C; Mangano P; Carnevali S; Rovati G; Sala A
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():115-25. PubMed ID: 25839425
[TBL] [Abstract][Full Text] [Related]
16. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation.
Zhang XY; Wang XR; Xu DM; Yu SY; Shi QJ; Zhang LH; Chen L; Fang SH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Exp Ther; 2013 Aug; 346(2):328-41. PubMed ID: 23750020
[TBL] [Abstract][Full Text] [Related]
17. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.
Liu T; Barrett NA; Kanaoka Y; Yoshimoto E; Garofalo D; Cirka H; Feng C; Boyce JA
J Immunol; 2018 Feb; 200(3):915-927. PubMed ID: 29282304
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion.
Kristen AV; Ackermann K; Buss S; Lehmann L; Schnabel PA; Haunstetter A; Katus HA; Hardt SE
Cardiovasc Pathol; 2013; 22(4):280-6. PubMed ID: 23410819
[TBL] [Abstract][Full Text] [Related]
19. TNF regulates leukocyte-endothelial cell interactions and microvascular dysfunction during immune complex-mediated inflammation.
Norman MU; Lister KJ; Yang YH; Issekutz A; Hickey MJ
Br J Pharmacol; 2005 Jan; 144(2):265-74. PubMed ID: 15655512
[TBL] [Abstract][Full Text] [Related]
20. Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells.
Sjöström M; Johansson AS; Schröder O; Qiu H; Palmblad J; Haeggström JZ
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):e37-41. PubMed ID: 12816881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
